mirvetuximab soravtansine-gynx
Restricted to Oncology for use in the outpatient setting. Insurance certification and PAP eligibility will be reviewed for each case before usage, and a plan developed for drug therapy in each case.
Reviewed: Jan. 2023 (Elahere)
Spotlight Mirvetuximab Sorvatansine-gynx (Elahere)
Restricted to Oncology for use in the outpatient setting. Insurance certification and PAP eligibility will be reviewed for each case before usage, and a plan developed for drug therapy in each case.
Reviewed: Jan. 2023 (Elahere)
Spotlight Mirvetuximab Sorvatansine-gynx (Elahere)